Optex Systems Holdings, Inc. — FY2020 Form 10-K Summary
Reporting period: Fiscal year ended September 27, 2020, comprising 52 weeks. The filing was signed December 17, 2020. Although the request references “2020 Q4,” this filing is an annual Form 10-K and reports full-year results, not a standalone fourth quarter.
Business Context
Optex manufactures optical sighting systems, periscopes, surveillance and night-vision assemblies, optical coatings, and related components primarily for U.S. Department of Defense applications. Products support Abrams, Bradley, Stryker, and other military vehicles and are sold directly to government agencies, defense primes, foreign military customers, and selected commercial customers. Operations comprise the Richardson, Texas facility and the Applied Optics Center in Dallas, Texas.
Approximately 89% of fiscal 2020 revenue came from five major customers: U.S. government agencies contributed 50%, three major defense contractors contributed 19%, 6%, and 5%, and one commercial customer contributed 9%. Approximately 92% of revenue was domestic and 8% was from Canada.
Financial Performance and Liquidity
| Metric | FY2020 | FY2019 | Change |
|---|---|---|---|
| Revenue | $25.890 million | $24.530 million | +5.7% |
| Gross margin | $6.088 million; 23.5% | $6.253 million; 25.5% | Margin down 2.0 percentage points |
| Operating income | $2.883 million; 11.1% | $3.197 million; 13.0% | Down $0.314 million |
| Income before taxes | $2.356 million | $4.518 million | Down $2.162 million |
| Net income | $1.825 million | $5.668 million | Down $3.843 million |
| Net income applicable to common shareholders | $1.227 million | $3.800 million | Down $2.573 million |
| Basic and diluted EPS | $0.14 | $0.45 | Down $0.31 |
| Adjusted EBITDA | $3.328 million | $3.680 million | Down $0.352 million |
| Backlog | $16.3 million | $24.6 million | Down 33.7% |
| New orders | $17.6 million | $25.8 million | Down 31.8% |
Revenue growth was driven by higher periscope and sighting-system shipments, including Improved Commander Weapon Sight deliveries, partially offset by lower sales of other products. Cost of sales increased faster than revenue, reflecting higher manufacturing spending and product-mix changes.
The decline in pretax and net income was materially affected by non-operating items. The company recorded a $0.508 million non-cash loss from the change in fair value of warrant liabilities, compared with a $1.344 million non-cash gain in FY2019. FY2020 also included $0.531 million of income-tax expense, compared with a $1.150 million tax benefit in FY2019, including the prior-year release of a deferred-tax valuation allowance.
Cash and cash equivalents were $4.700 million at year-end, compared with $1.068 million in FY2019. Working capital increased to $14.3 million from $11.7 million. Operating activities generated $3.911 million of cash; investing activities used $0.152 million, principally for capital expenditures; and financing activities used $0.127 million, including $0.200 million for share repurchases.
Accounts receivable were $2.953 million and inventory was $8.791 million at year-end. The company had $0.377 million outstanding under its BBVA revolving credit facility, which has a $2.25 million principal capacity and matures April 15, 2022. Management stated that the company was in compliance with its financial covenants. Total liabilities were $6.369 million, including $1.454 million of operating lease liabilities and a $2.544 million warrant liability.
Material Changes Versus FY2019
- Revenue increased $1.4 million, or 5.7%, but gross margin declined from 25.5% to 23.5%.
- Operating income declined 9.8% because of lower gross margins and higher general and administrative expenses.
- Net income applicable to common shareholders decreased 67.7%, primarily because of the warrant fair-value swing, higher tax expense, and lower operating income.
- Backlog decreased $8.3 million, or 33.7%, with particularly sharp declines in periscopes and Applied Optics Center orders.
- New orders fell $8.2 million, or 31.8%, to $17.6 million. Approximately $13.9 million of FY2020 orders remained deliverable in FY2021 and later.
- The company adopted ASC 842, recognizing a $1.416 million right-of-use asset and $1.454 million of operating lease liabilities at year-end.
- The company repurchased 105,733 common shares for $0.200 million under a $1.0 million authorization and issued 300,000 restricted shares to three independent directors.
Guidance, Outlook, Risks, and Unusual Items
Management did not provide full-year FY2021 revenue or earnings guidance. It anticipated a 20%–25% reduction in revenue volume during the first six months of FY2021 compared with the first six months of FY2020 because of COVID-19-related delays in government contracting, testing, inspections, and defense-supply-chain activity. Management was evaluating cost-reduction measures and stated that it believed the company was in a strong position to withstand significant adverse financial impacts, but also warned that further order delays could reduce FY2021 revenue and profitability.
COVID-19 caused a three-to-six-month extension in the cycle from bid proposal to contract award. The company remained open as essential defense infrastructure and reported minimal production disruption during FY2020, but experienced lower orders and backlog. Defense budget reallocations away from Army ground systems and uncertainty in foreign military sales were additional pressures.
- Customer concentration creates material revenue risk; more than 89% of revenue came from five customers.
- Approximately 86% of contracts contain termination-for-convenience clauses. The company was not aware of pending terminations and stated that these clauses generally permit recovery of incurred costs plus a reasonable fee.
- Most contracts are fixed-price, exposing the company to labor, material, supplier, production, and cost-overrun risk. No accrued loss provisions for loss contracts or cost overruns were reported at year-end.
- Approximately 4% of material requirements were single-sourced across 12 suppliers, representing approximately 31% of active supplier order values. Certain components could require four to six months or more to qualify an alternative source.
- Warrant liabilities are Level 3 fair-value measurements and remain sensitive to stock price and volatility assumptions. The company had 4,125,200 warrants outstanding at a $1.50 exercise price, expiring August 26, 2021.
- The company had $1.227 million of net deferred-tax assets after a $0.963 million valuation allowance. Utilization is subject to an IRS Section 382 limitation.
- Warranty reserves increased to $83,000 from $46,000, principally because of increased optical-assembly shipments and warranty-return activity.
- No material legal proceedings, pending defective-pricing claims, pending government-contract terminations, or long-lived-asset impairments were disclosed.
Subsequent Events
- An updated CEO employment agreement became effective October 15, 2020, with a base salary of $284,645 and a target performance bonus equal to 30% of base salary.
- From September 28 through December 10, 2020, the company repurchased an additional 170,408 shares for $0.347 million. Cumulative repurchases under the plan reached 276,141 shares for $0.547 million as of December 10, 2020.
- The board approved executive bonuses of $48,000 for the CEO and $37,000 for the CFO in December 2020.
Investor Verification Points
- Verify the sustainability of the $16.3 million backlog and the timing of the $13.9 million scheduled for delivery in FY2021 and later.
- Assess whether the anticipated 20%–25% first-half FY2021 revenue decline occurred and whether subsequent contract awards restored order momentum.
- Reconcile reported net income with operating performance by separately evaluating warrant fair-value changes and deferred-tax benefits or expenses.
- Monitor gross-margin recovery, manufacturing costs, product mix, and warranty-return trends.
- Review liquidity after subsequent share repurchases, lease obligations, working-capital requirements, and the $0.377 million credit-facility balance.
- Evaluate dilution from 4.125 million outstanding warrants, 182,000 unvested RSUs, and restricted shares issued to directors.
- Assess exposure to U.S. government budget changes, customer concentration, fixed-price contracts, COVID-19-related procurement delays, and single-source suppliers.
- Confirm the company’s ability to renew or replace the Richardson facility lease expiring March 31, 2021 and manage the Applied Optics Center lease through October 31, 2021.